Formed in 2013, OcuDyne is a clinical-stage medical device company developing minimally invasive therapies for age-related macular degeneration by improving blood flow to the eye. Its work grew from research linking compromised ocular perfusion with AMD progression, and its investigational OPTiC system has advanced through clinical trials in Argentina and Australia.
Ocugen, IncOcugen is a biotechnology company developing investigational gene therapies, biologics, and vaccines, with a primary focus on retinal diseases and blindness. Founded in 2013 by Shankar Musunuri and Uday Kompella, the company’s pipeline includes modifier gene therapy candidates for retinitis pigmentosa, Stargardt disease, and geographic atrophy, alongside a biologic candidate and inhaled vaccine programs.MALVERN, PA
Outlook Therapeutics, IncOutlook Therapeutics is a biopharmaceutical company developing and commercializing ophthalmic therapies for retinal diseases, centered on LYTENAVA™ (bevacizumab-vikg) for neovascular, or wet, age-related macular degeneration. LYTENAVA is the first and only FDA-approved ophthalmic bevacizumab formulation for wet AMD in the United States, and is also authorized for the same use in the European Union and United Kingdom. The company is building on its clinical development experience to expand access to ophthalmic bevacizumab and pursue additional retinal-disease applications.ISELIN, NJ
Peregrine Surgical LLCFounded in 1991, Peregrine Surgical LLC makes and develops single-use ophthalmic and vitreoretinal surgical devices for OEM and private-label partners. Its roots in fiber optics show in products such as illuminated laser probes and light pipes, while its in-house development and packaging services help medical-device companies move products from prototype to market. Peregrine performs product development to meet U.S. Code of Federal Regulations Title 21 and ISO 13485 requirements.NEW BRITAIN, PA
Volk OpticalFounded in 1974 by Dr. David Volk, Volk Optical is a Mentor, Ohio, medical-device company built around a mission to eradicate preventable blindness. Now part of Halma plc, it has spent five decades refining ophthalmic visualization for eye-care professionals, including its distinctive double-aspheric optical design and portable fundus imaging work.MENTOR, OH